Xcout Intel
ImmunoScape competitors & alternatives
The 12 closest competitors and alternatives to ImmunoScape among biotechnology companies — ranked by similarity to what ImmunoScape actually does, not by market-cap band.
Subscribe to see ImmunoScape’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About ImmunoScape
ImmunoScape is a biotechnology company developing combination cancer therapies, specifically utilizing a novel seed-and-boost approach designed to deliver anti-tumor efficacy at a lower cost. The company serves the biopharmaceutical and oncology healthcare sectors.
ImmunoScape at a glance
ImmunoScape is a biotechnology company headquartered in Singapore. Xcout tracks 13 named people at ImmunoScape, including Romi Chandiramani (CHIEF FINANCIAL OFFICER).
ImmunoScape leadership
- Romi ChandiramaniCHIEF FINANCIAL OFFICER
- Choon-Peng NgCHAIRMAN OF THE BOARD
- Michael FehlingsCHIEF EXECUTIVE OFFICER, CO-FOUNDER
- Alessandra NardinVP STRATEGY
- Evan NewellCO-FOUNDER/ADVISOR
- Andreas WilmVP COMPUTATIONAL BIOLOGY
7 more named people on record for ImmunoScape, with roles, board committees and tenure — see the full roster →
Top 12 ImmunoScape competitors
Ranked by semantic similarity — how close each company is to ImmunoScape by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
ImmunityBio, Inc. is a clinical-stage biotechnology firm, founded in 2014 and based in San Diego, California. The company is focused on developing groundbreaking therapies and vaccines designed to treat a wide array of cancers and infectious diseases. Its innovative approach relies on a comprehensive suite of immunotherapy and cell therapy platforms. These advanced technologies include novel antibody-cytokine fusion proteins, synthetically engineered immunomodulators, cutting-edge vaccine technologies, natural killer (NK) cell therapies, and strategies that harness the adaptive (T-cell) immune system. ImmunityBio currently has several therapeutic candidates in advanced clinical development, with agents undergoing Phase II or III trials. These investigational treatments are aimed at various liquid and solid tumors, such as bladder, pancreatic, and lung cancers, as well as significant infectious pathogens including SARS-CoV-2 and HIV. The company actively engages in strategic partnerships, holding collaboration agreements with esteemed organizations like the National Cancer Institute, the National Institute of Deafness and Communication Disorders, and Amyris, Inc. Additionally, ImmunityBio has secured licensing agreements with numerous entities, including CytRx Corporation, EnGeneIC Pty Limited, GlobeImmune, Inc., Infectious Disease Research Institute, Sanford Health, Shenzhen Beike Biotechnology Co. Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc.
Similar biotechnology company
ImmPACT Bio is a biotechnology company developing next-generation cancer immunotherapies, including dual-targeted CAR T-cell therapies. Its programs are intended to serve patients with B-cell malignancies and potentially other cancers, including solid tumors.
Similar biotechnology company
BioEclipse Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in California. The company is focused on researching and developing a novel generation of targeted immunotherapies and treatments for oncology.
Similar biotechnology company
Irazu Oncology, LLC is a biotechnology company that develops cancer immunotherapies utilizing bacterial outer membrane vesicles. The company creates off-the-shelf treatments designed to activate anti-tumor immune responses through a scalable manufacturing process, aiming to provide more accessible and affordable therapeutic options for cancer patients.
Similar biotechnology company
Surface Oncology is a clinical-stage biotechnology company focused on developing immunotherapies that target the tumor microenvironment and enhance anti-tumor immune responses. Its programs are intended for cancer patients and are developed for use by oncology physicians and healthcare systems, with potential pharmaceutical partnerships.
Similar biotechnology company
ImmunoPhotonics, Inc. is a privately owned clinical-stage biopharmaceutical and pharmaceutical manufacturing company located in St. Louis, Missouri, specializing in interventional immuno-oncology.
Similar biotechnology company
Checkmate Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on developing proprietary technology to stimulate the immune system to combat cancer.
Biotech
Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to the advancement and commercialization of an immunomodulatory platform technology. This innovative platform aims to provide therapeutic solutions for cancer and infectious diseases in both human and animal health. The company's core product is MIE-101, a nanoparticle-based treatment sourced from the cowpea mosaic virus, which has demonstrated non-infectious characteristics in mice, dogs, and humans. Headquartered in Novato, California, the company commenced operations in 2020.
Similar biotechnology company
IO Biotech, Inc. is a clinical-stage biopharmaceutical company that develops novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines. Its proprietary T-win® technology is designed to modulate the tumor microenvironment by targeting both tumor cells and immune-suppressive cells, aiming to improve treatment outcomes for patients with melanoma and other tumor types.
Similar biotechnology company
ImmunOs Therapeutics AG is a biotechnology company that develops treatments for cancer and inflammatory diseases by harnessing the human immune system. The company focuses on immuno-oncology and autoimmune therapies through a dedicated drug pipeline.
Similar biotechnology company
KAHR Bio is a biotechnology company developing immunotherapies, particularly engineered fusion-protein therapies intended to activate or modulate immune responses against cancer. Its work is aimed at oncology patients and potential biopharmaceutical partners.
Similar biotechnology company
ImaginAb, Inc. is a global biotechnology company headquartered in California, with operations in Los Angeles and San Diego. It focuses on developing next-generation imaging and radiopharmaceutical products for cancer immunology.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of ImmunoScape and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for ImmunoScapeand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →